TSPO and early-onset autosomal dominant Alzheimer disease: The SVCA method for 11C-(R)-PK11195 has been extensively used to study several neurological and psychiatric conditions, including Alzheimer’s disease [16, 17], multiple sclerosis [34], traumatic brain injury [18], schizophrenia [19] and changes in TSPO expression in normal ageing [35].